Abstract

BackgroundPrimary Immunodeficiency Disorders (PIDs) are well-known disorders in the West. but the recognition and diagnosis of these disorders is challenging in developing countries. We present the spectrum of PIDs seen at a tertiary care center in Pakistan, identified using clinical case definitions and molecular methods. MethodsA retrospective chart review of children suspected to have PID was conducted at the Aga Khan University Hospital (AKUH) Karachi, Pakistan from 2010 to 2016. Data on demographics, clinical features, family history of consanguinity, sibling death, details of laboratory workup done for PID and molecular tests targeted panel next generation sequencing (NGS) or whole exome sequencing (WES) performed at the Geha laboratory at Boston Children’s Hospital, USA was collected. The study was exempted from the Ethical Review Committee of AKUH. ResultsA total of 43 children visited the hospital with suspected PID during the study period. Genetic testing was performed in 31/43 (72.1%) children. A confirmed diagnosis of PID was established in 20/43 (46.5%) children. A pathogenic gene variant was identified in 17(85%) of the 20 confirmed cases (Table 1). Twelve (60%) of the confirmed cases of PID were male. The most common presenting symptom was recurrent diarrhea 11/20 (55%). The mean (±S.D) age of the cases at the time of diagnosis was 4.2 (±4.1) years. Chronic granulomatous disease (CGD) was the most common 6/20 (30%) disorder, followed by severe combined immunodeficiency (SCID) 3/20 (15%), leukocyte adhesion deficiency (LAD) 3/20 (15%), agammaglobulinemia/hypogammaglobulinemia 3/20 (15%), and Hermansky-Pudlak Syndrome (HPS) 2/20 (10%). Wiskott-Aldrich Syndrome, Immunodeficiency Centromeric Instability and Facial Anomalies Syndrome (ICF 2), Trichohepatoenteric syndrome (TRES), and C3 deficiency were each diagnosed once {1/20 (4.3%) each} (Table 1). Of these 20 confirmed cases, almost all 19/20 (95%) had a family history of consanguinity. Sibling death was reported in 5/20 (25%) of these cases. Five out of the 20 (25%) children died over the 7-year period for various reasons. ConclusionPIDs are not uncommon in Pakistan; their diagnosis may be missed or delayed due to the overlapping of clinical features of PID with other diseases and a lack of diagnostic facilities. There is a need to build capacity for early recognition and diagnosis of PIDs to decrease morbidity and mortality.

Highlights

  • Primary immunodeficiency disorders (PIDs) are a heterogeneous group of genetic disorders characterized by an impaired ability of the immune system to produce a normal immune response

  • A total of 43 children visited the hospital with suspected Primary Immunodeficiency Disorders (PIDs) during the study period

  • This study aims to report the spectrum of PID cases observed at a tertiary care center in Pakistan, with a focus on the molecular diagnosis in this patient population over the last 7 years

Read more

Summary

Introduction

Primary immunodeficiency disorders (PIDs) are a heterogeneous group of genetic disorders characterized by an impaired ability of the immune system to produce a normal immune response This is due to inherited defects in either cellular or humoral immunity, which results in a spectrum of issues such as recurrent infections, allergies, autoimmunity, and malignancies.. The data obtained from these registries often underestimate the true prevalence, because not all cases are reported to these registries, and due to ambiguity in what constitutes a PID case, some cases are missed These issues are compounded in developing countries because of the lack of physician training in identification of these disorders and the limited access to diagnostics in these countries. The burden of PID varies by region, being highest in the United States of America (USA), followed by Europe, Latin America, Middle East, Asia, and Africa.4 This frequency may be biased by the availability of resources for diagnosis of these disorders. We present the spectrum of PIDs seen at a tertiary care center in Pakistan, identified using clinical case definitions and molecular methods

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call